Shares of Rezolve AI (NASDAQ:RZLV) surged approximately 12% on Tuesday after shareholders voted overwhelmingly in favor of a share buyback program worth up to $300 million. The approval gives the company a powerful tool to return capital to investors, pending final clearance from a UK court.
At Tuesday's intraday price of $2.92, the buyback would cover roughly 102.7 million shares, representing about 25.8% of the 398.83 million shares outstanding. The stock traded between $2.61 and $2.99 during the session, with volume exceeding 24.4 million shares by early afternoon—already surpassing the average daily volume of 17.64 million.
The buyback mandate is notably large relative to the company's market value. With an implied equity value of approximately $1.16 billion at current prices, the program could repurchase over a quarter of the company's market capitalization. For context, the buyback amount is about 6.4 times Rezolve's fiscal 2025 revenue of $46.8 million and roughly 83% of the company's fiscal 2026 revenue guidance of $360 million.
Market Context and Performance
Rezolve AI's stock has experienced significant volatility over the past year, with a 52-week range of $2.05 to $8.45. Tuesday's gain came as the broader market also moved higher, with the Invesco QQQ Trust (NASDAQ:QQQ) rising about 1.6% and the iShares Russell 2000 ETF (NYSEARCA:IWM) gaining approximately 0.6%. However, Rezolve's outperformance was substantial, reflecting investor enthusiasm for the buyback news.
The company's shares have declined roughly 65% from their 52-week high but remain up 42% from the low. The buyback announcement signals management's confidence in the company's intrinsic value, with CEO Daniel M. Wagner stating that the public valuation "does not come close" to matching the size of the business.
Timing and Execution Details
While shareholders have approved the buyback, the company still requires approval from a UK court for a capital reduction plan. Rezolve expects this approval by mid-September. The capital reduction involves canceling £480 million from the company's share premium account, which would create a distributable reserve available for share repurchases if the court approves.
Rezolve plans to execute the buyback through BTIG, utilizing open market purchases, block trades, or private transactions. Importantly, the company is not obligated to repurchase any specific number of shares and retains the flexibility to suspend, modify, or terminate the program at any time. This flexibility introduces an element of uncertainty for investors, as the actual pace and extent of buybacks remain discretionary.
Financial Performance and Outlook
Rezolve reported first-quarter 2026 unaudited revenue of approximately $60 million, representing about one-sixth of its full-year revenue target. The company's fiscal 2026 revenue guidance of $360 million is roughly 7.5 times its fiscal 2025 revenue of $46.8 million. Management has set an exit annualized recurring revenue (ARR) target of at least $500 million by year-end 2026, with more than 1,000 enterprise customers already onboard.
The buyback program is a significant commitment relative to the company's financials. At $300 million, it represents about 5 times the first-quarter 2026 revenue and nearly 83% of the full-year revenue outlook. This aggressive capital return strategy underscores management's belief that the stock is undervalued and that returning capital to shareholders is the best use of corporate resources.
Investor Considerations
While the buyback approval is a positive signal, investors should note several risks. The program is subject to UK court approval, which may not be granted until mid-September. Additionally, the company has no obligation to repurchase any shares, and the program could be changed or terminated at any time. The stock's recent performance—down 65% from its high—highlights the volatility inherent in this name.
Data from Public.com shows the company's market value at $1.04 billion as of June 29, with trailing-12-month revenue of $46.8 million. The buyback, if fully executed, would represent a substantial portion of the company's market cap and could provide meaningful support to the stock price. However, the lack of a mandatory repurchase schedule means that the actual impact will depend on management's execution.
